-
At-Home Self-Collection for Pre-Transplant Patients
Rochester, MN
The objectives of this study are to determine whether adequate blood volumes can be obtained with the Tasso+ device for anti-HLA antibody testing, to compare MFI levels from at-home collected capillary blood to venous blood, and to obtain user feedback and experiences from patients.
-
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
Rochester, MN; Jacksonville, FL
The purpose of this study is to examine the effectiveness of a phone call ≤ 30 minute per session, 12-session, weekly individual health-coaching intervention, completed over 12-16 weeks in adults on the lung transplant waiting list versus usual transplant care.
-
Pro-active Genetic Testing in Kidney Transplant Patients
Scottsdale/Phoenix, AZ; Rochester, MN
The purpose of this study is to determine the prevalence of genetic mutations of cancer in kidney transplant patients receiving care at Mayo Clinic Arizona.
-
Pre-Transplant Patients’ Experiences with Uncertainty
Jacksonville, FL; Rochester, MN
The primary research goal of this qualitative study is to explore how patients experience the time between transplant listing and transplantation especially with regards to uncertainty.
-
Obesity Treatment Outcomes in Liver Transplant Recipients
Scottsdale/Phoenix, AZ
The purpose of this study is to prospectively evaluate the safety and effectiveness of standard of care, individualized, comprehensive weight loss interventions in carefully selected patients with obesity undergoing liver transplant evaluation, including utilization of best lifestyle modifications and guidance to promote a healthy weight, possible medical therapy using FDA-approved weight loss medications and EBMTs with or without concomitant medical therapy.
-
Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation
Jacksonville, FL
The purpose of this study is to describe the association between Prospera dd-cfDNA measures and other diagnostic tests used to detect heart allograft rejection and/or njury, including histology, echocardiography and DSA, in the first post-transplant year. Additionally, to inform rates of clinical outcomes in a contemporary cohort of adult heart transplant recipients to determine power for a future randomized, controlled clinical trial.